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Abstract 
In cartilage tissue engineering bioreactors can create a controlled environment to 
study chondrocyte behavior under mechanical stimulation or produce chondrogenic 
grafts of clinically relevant size. Here we present a novel bioreactor, which combines 
mechanical stimulation with a two compartment system through which nutrients can 
be supplied solely by diffusion from opposite sides of a tissue engineered construct. 
This design is based on the hypothesis that creating gradients of nutrients, growth 
factors and growth factor antagonists can aid in the generation of zonal tissue 
engineered cartilage. Computational modeling predicted that the design facilitates the 
creation of a biologically relevant glucose gradient. This was confirmed by 
quantitative glucose measurements in cartilage explants. In this system it is not only 
possible to create gradients of nutrients, but also of anabolic or catabolic factors. 
Therefore, the bioreactor design allows control over nutrient supply and mechanical 
stimulation useful for in vitro generation of cartilage constructs that can be used for 
the resurfacing of articulated joints or as a model for studying OA disease 
progression.  
 
 
 
Keywords: Dual compartment, bioreactor, gradients, mechanical stimulation, cartilage 
tissue engineering 
 
  
 Page 2 of 35
Ti
ss
ue
 E
ng
in
ee
rin
g 
Pa
rt 
C:
 M
et
ho
ds
A
 d
ua
l f
lo
w
 b
io
re
ac
to
r w
ith
 c
on
tro
lle
d 
m
ec
ha
ni
ca
l s
tim
ul
at
io
n 
fo
r c
ar
til
ag
e 
tis
su
e 
en
gi
ne
er
in
g 
(do
i: 1
0.1
08
9/t
en
.T
EC
.20
12
.04
35
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
3 
 
Introduction 
If left untreated, critical size cartilage defects will lead to degenerative diseases like 
osteoarthritis (OA) [1, 2]. Clinical techniques such as autologous chondrocyte 
implantation (ACI), matrix-induced chondrocyte implantation and microfracture have 
demonstrated to improve healing of critical size defects [3-5]. Although the mentioned 
techniques have shown positive results, the regenerated cartilaginous tissue is of 
less quality and neo-tissue integration with existing cartilage remains challenging [6-
11]. An alternative strategy is the generation of engineered tissues of clinically 
relevant amount [12] or size [13] in vitro, which can be used for surface defect repair. 
For the production of such tissue engineered constructs, bioreactor systems are 
essential, as they can provide control over the in vitro environment and allow for 
creating optimal conditions for neo-tissue formation [14].  
Cartilage can be considered as a simple tissue, as it only contains one cell type and 
only two major extracellular matrix (ECM) components, proteoglycans and collagen 
type II. However, it is complex in the sense that it is a layered anisotropic structure 
which is required to absorb strong mechanical forces, distribute load and lubricate the 
joint [15, 16]. These functions arise in part from the zonal organization of the tissue. 
Collagen fibers, responsible for absorbing and distributing the load, are orientated 
parallel along the synovial surface and become perpendicularly orientated with depth 
anchoring in the subchondral bone plate. This results in a fountain-like structure with 
the purpose of distributing load and retrieving the tissue’s original shape [17]. 
Glycosaminoglycans (GAGs) are distributed inhomogeneously as the articular 
surface is almost void of these molecules and their concentration increases with 
depth [18]. Water is attracted by the negatively charged proteoglycans. Upon 
deformation, water is expelled from the tissue, which flows back when the tissue 
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relaxes. Although several bioreactor studies have demonstrated the ability to 
stimulate sulphated glycosamoniglycan (sGAG) deposition, a native distribution of 
sGAGs in tissue engineered constructs has yet to be obtained. In addition, the 
fountain-like structure of collagen fibers has so far not been generated in vitro. As a 
result it remains a challenge to engineer cartilaginous tissue in vitro that possesses 
the mechanical properties of native articular cartilage.  
Several bioreactors for cartilage tissue engineering have been described. In these 
system nutrients are usually supplied through perfusion, creating shear stress, or 
static-like culture as in a culture dish. However, articular cartilage is not subjected to 
an external active flow and except for the perichondrium it does not receive nutrients 
from the sides. It is situated between synovial fluid and the subchondral bone plate, 
which physically separates the articular cartilage from the bone marrow. It has been 
postulated that cartilage is supplied with nutrients from the subchondral bone and 
from the synovial fluid [19, 20]. Applying this feature to in vitro culture was described 
by Chang et al, and can be mimicked in transwell cultures. However, no mechanical 
stimulation can be applied in this system [21]. Chondrocytes in their natural 
environment are subjected to mechanical load. Therefore, bioreactors for cartilage 
tissue engineering that are equipped with a compression module more closely 
resemble cartilage’s in vivo environment. Load can either be applied by confined [22], 
sliding [23] or rotating compression [24]. Demarteau et al showed that under 
perfusion and confined compression sulphated glycosaminoglycan metabolism was 
increased in cell-loaded PEOT/PBT block co-polymer foam scaffolds, but this design 
did not originate in an inhomogenous sGAG distribution as in native cartilage [22]. 
Kock et al showed production of collagen II next to a homogenous distribution of 
sGAGs under sliding indentation, but this did not result in fountain like orientation of 
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the collagen network [23]. The stimulatory effect of compression on the expression of 
zone specific genes was shown by Grad et al indicating the importance of 
mechanical stimulation in the regeneration of functional chondrogenic constructs in 
vitro [25, 26]. 
Here, we describe a bioreactor design in which nutrient supply from both the synovial 
and subchondral side can be mimicked. This configuration will facilitate formation of 
gradients of nutrients, growth factors and growth factor antagonists through the 
cartilage tissue. In  addition, the bioreactor is complemented with options for confined 
compression. We hypothesize that the ability to create gradients of relevant factors 
combined with confined load will aid in the generation of neo-cartilage better 
resembling cartilage’s natural organization and mechanical properties. In this study 
we introduce the basic design of a dual compartment, compression equipped novel 
bioreactor that can be used to engineer cartilage or osteochondral constructs in vitro.   
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Materials and methods 
Bioreactor design 
The dynamic (Figure 1A) and static (Figure 1B) bioreactors were designed in 
Solidworks 2009, Edition SP4.1. The stainless steel housing of the dynamic 
bioreactor was produced by electrical discharge machining (EDM) effectively creating 
a construct chamber of 1cm3 (Figure 1A). Removable round polymethylmethacrylaat 
(PMMA) windows were installed at the front and back side of the housing and 
allowed for placement of the construct into the chamber. Windows contained a nitrile 
butadiene rubber (NBR) O-ring ensuring a tight seal preventing leakage and 
infection.  
The complete chamber has a height of 13 mm and a width and depth of 10mm. 
Explants were placed in a 4mm high insert. Articular cartilage constructs were placed 
in a square insert (Figure 1C). Osteochondral plugs were placed in a round insert 
(Figure 1C). The inserts were placed in the reactor chamber on top of a 4,5mm high 
perforated polycarbonate plate (Figure 1C, bottom) that allowed for diffusion of 
nutrients and metabolites. The square inserts were combined with a 4,5mm high 
perforated metal compression insert and the round inserts were combined with a 
7mm diameter rounded Teflon head (Figure 1D). Above and below the inserts are 
medium reservoirs with an approximate volume of 270μL. 
Culture medium within the channels of the perforated plates is refreshed by diffusion 
from the top and bottom medium reservoirs. The medium reservoirs are in turn 
refreshed by laminar flow of medium from four 10mL syringes (Hamilton, Reno, USA) 
which are driven by a syringe pump (kdScientific, Holliston, USA).  
A stainless steel plunger is attached to the compression insert. This plunger applies 
top down compressional force on the tissue engineered constructs by means of a 
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separate steppenmotor. The exerted force is continuously monitored by a Futek 
pressure sensor (model LSB200, type FSH00105) and is configured and controlled 
via labVIEW software (National Instruments, Austin, USA).  
Additionally, we also designed a polycarbonate static bioreactor, which is identical to 
the dynamic bioreactor in the sense that samples of the same dimensions can be 
inserted and the volume of both medium reservoirs are identical to the dynamic 
bioreactor (Figure 1B). The inlets were provided with a screw rod to enable the 
insertion of this bioreactor in a dynamic system. The device was placed in a custom-
made four well plate during culture. The static bioreactor lacked modalities for 
mechanical compression. 
 
Material source 
Knees of 10-12 month old calves were collected from the local abattoir. Femoral 
condyles were sterily exposed by removing the muscles and patella.  
For the articular cartilage explant model, cartilage slices were made with a custom 
made slicer (figure 1E, bottom) to obtain slices of equal height. Since this slicer could 
not slice through the calcified zone of the cartilage, it was ensured that slices did not 
contain bone contamination. Cubes of 4.5mm by 4.5mm by 1-1.4mm in height were 
punched from the slices with a 4-frame stainless steel knife (figure 1C, top) and a 
puncher. The cubes were then transferred to the polycarbonate insert (Figure 1C, 
second from the top) and loaded into the bioreactor chamber together with the metal 
compression and perforated bottom inserts. Explants were always cultured with the 
synovial side oriented upwards and the subchondral side downwards. The 4 explants 
were consistent in size. The thickness of the explants depended on the region of 
harvesting (figure 1F).  
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For the osteochondral model, 7mm diameter osteochondral plugs were punched from 
the condyles. These explants were about 6mm in height to assure that cartilage and 
bone were properly attached after explantation. Afterwards bone was removed to 
adjust the explant’s height to 3mm and they were transferred to a polycarbonate 
insert (Figure 1C, third from the top) and loaded into the chamber together with the 
Teflon compression and perforated bottom insert. 
 
Computational modeling 
Computational fluid dynamics (CFD) of the fluid flow and diffusion in culture 
conditions were set-up and solved in the MEMS module (microfluidics – flow with 
species transport – Incompressible-Navier Stokes) in Comsol Multiphysics version 
3.5a software (Comsol, Zoetermeer, The Netherlands). 
The Navier-Stokes equation that was solved for incompressible fluid dynamics is as 
defined by Eq. 1: 
Fpuuu
t
u



)(2 
       (1) 
0 u  
where ρ is the fluid density (kg m-3), u is the velocity field (m s-1), t is the time (s), η is 
the dynamic viscosity of the fluid (kg m-1 s-1),  is the del operator, p is the pressure 
(Pa) and F represents other forces (gravity or centrifugal force), which in this case 
equals 0. It was assumed that medium could not flow through the cartilage explants. 
Fluid flow was set at a velocity of 2.65 x 10-3 m/s (=0.5 mL/min). 
Species transport was coupled to Navier-Stokes. Glucose and oxygen concentrations 
in the bioreactor chamber were modeled in steady state using the following 
assumptions i) Walls in different conditions were considered rigid and impermeable, 
ii) no-slip boundary conditions were applied to surfaces, iii) the glucose diffusion 
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constant (Ɖ) in water was set to 9.0 x 10-10 m2/s and in cartilage was 3.0 x 10-10 m2/s 
[27, 28]. Initial concentration of glucose in the top compartment was 25 mmol/L, 
representing high glucose DMEM, and was 0mmol/L in the bottom compartment, 
representing DMEM without glucose. The glucose consumption rate of chondrocytes 
in cartilage was considered to be  0.62 x 10-10 mol/(m3*s) (calculated from [29]).  
 
For the computation of oxygen gradients, we corrected for the difference in oxygen 
consumption in different layers [30]. Therefore, the explants were divided into ten 
different zones with the top two layers having a different consumption rate compared 
to the bottom eight layers. The rationale behind this division was described by 
Heywood et al, where oxygen consumption rates were measured in superficial and 
deep zone chondrocytes. Superficial zone cells were isolated from the top 20% of the 
tissue depth and deep zone cells from the remaining 80% [30]. Oxygen diffusion 
constant (Ɖ) in water was 3.05 x 10-9 m2/s and in cartilage was 2.2 x 10-9 m2/s [31]. 
Initial oxygen concentration in the top compartment was 0.254mmol/L, representing 
100% air saturation, and 0.127mmol/L in the bottom compartment, representing 50% 
air saturation. The oxygen consumption rate in the top two zones was 3.53 x 10-6 
mol/(m3*s) and in the bottom eight zones 6.758 x 10-6 mol/(m3*s). Consumption rates 
were calculated after Heywood et al [30]. 
 
It has to be noted that for glucose the consumption rate was assumed homogenous 
throughout the cartilage. However, as oxygen consumption rates are different in 
various layers, the same probably also holds for glucose consumption, but this is not 
supported by literature data. 
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Explants culture 
Static culture 
Cartilage explants were transferred to polycarbonate 4-chamber (comparable to 
figure 1C) inserts and placed in the static bioreactor (figure 1B). A ring was used to 
separate the two medium compartments and the bioreactor was placed in a custom 
made 4-well plate. The top and bottom compartments were filled with differentiation 
medium (DMEM, 100U/mL penicillin/100μg/mL streptomycin, 20mM ascorbic acid, 
40μg/mL proline, 100μg/mL sodium pyruvate, 1%Insulin Transferrin and Selenium 
premix,). In specific experiments, medium in the top compartment was supplemented 
with 1,5mg/mL hyaluronidase or collagenase. Volumes used were identical to those 
used in the dynamic bioreactor. Explants were cultured for 7 days without medium 
change in a humidified atmosphere at 37⁰C. 
 
Dynamic culture 
Cartilage explants in the 4-chamber polycarbonate inserts were placed between a 
compression module insert (figure 1D) and a perforated cover plate in the bioreactor 
chamber (figure 1A). The reactor was connected to a syringe pump with syringes of 
10mL creating two separate medium compartments. Both compartments were filled 
with 30mL of differentiation medium saturated with 20% air. The concentration of 
glucose in the top compartment was 25 mmol/L and in the bottom compartment was 
0 mmol/L. Medium flow was 0.5 mL/min. The culture was performed for 3 days at 
37⁰C in an incubation unit, which is previously described [12]. 
 
Viability 
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Cell viability in the chondral and osteochondral model was assessed after 24 hours of 
culture with 3 cycles of 1 hour compression followed by 7 hours of rest with a 
live/dead assay according to manufacturer’s protocol (Invitrogen, New York, USA). 
Live (green) and dead (red) cells were visualized with a separate FITC and Texas 
Red filters on a fluorescence microscope (Nikon Eclipse E600, USA) and 
microphotographs were taken with Qcapture acquisition software. These pictures 
were overlaid in Photoshop and the areas of dead cells and the total area were 
analyzed with ImageJ. 
 
Histology 
For histology, explants were dissected top to bottom and fixed in 10% buffered 
formalin at 4oC overnight and decalcified in 12.5% ethylenediaminetetraacetic acid 
(EDTA) dissolved in H2O (pH=8.0) at 4
oC for 4 weeks. The EDTA solution was 
refreshed every 7 days. Decalcified explants were embedded in CryomatrixTM 
(Thermo Fisher Scientific, USA). The cryomatrix blocks were sectioned in a cryotome 
into 10 µm thick longitudinal sections and then mounted onto Superfrost® Plus 
(Thermo Fisher Scientific, USA) glass slides.  
 
Safranin-O staining 
Safranin-O staining was performed as previously described [32]. In short, sections 
were hydrated for 10 minutes in demi water and stained with Fast Green for 3 
minutes, rinsed in 1% acetic acid and subsequently stained with Safranin-O for 5 
minutes and dehydrated in 96% EtOH, 100% EtOH and xylene for 2 minutes each. 
Section were dried and mounted with mounting medium.  
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Picrosirius Red 
To visualize collagen fibers sections were stained with the Picrosirius Red staining kit 
(BioSciences, San Jose, USA) according to the manufacturer’s protocol. Shortly, 
sections were hydrated for 10 minutes in demi water, stained with haematoxylin for 8 
minutes and rinsed in distilled water followed by staining with picrosirius red. The 
stained sections were washed in 70% EtOH for 45 seconds and dehydrated in a 
graded ethanol series. Collagen fibrils were visualized using a Nikon polarization 
filter. 
 
Microphotographs were taken using a light microscope (Nikon Eclipse E600, USA) 
and Qcapture acquisition software. Image analysis was performed using Image J 
software 
 
Glucose analysis 
After 3 days of dynamic culture, explants were physically separated into a top, middle 
and bottom part, weighed and, after mincing, dissolved in 50μL of PBS. After 3 days 
of incubation at room temperature the glucose concentration was analyzed using a 
Vitros DT60II medium analyzer (Ortho-Clinical Diagnostics, USA), assuming that 
chondrocytes were inactive and not consuming glucose. Ten samples per zone were 
analyzed and glucose content was corrected for the weight of the cartilage. 
 
Statistical analysis 
Statistical analysis was performed using a one-way ANOVA using SPSS version 19 
followed by Tukey post-hoc testing.  Differences were considered statistically 
significant at P<0.05 and are indicated with an asterisk.  
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Results  
  
  
Computational modeling of oxygen and glucose gradients 
To predict whether our bioreactor design allowed for the formation of biological 
relevant gradients of bioactive molecules a computational model was made using 
glucose and oxygen as representative molecules. We modeled the design with the 
square cartilage only explants. Additionally, two different types of inlets were 
modeled, namely a horizontal inlet and a diagonal inlet. The model predicted that 
with both inlets biological relevant gradients were formed for both oxygen and 
glucose (Figure 2). Interestingly, the two types of inlets created gradients that differed 
in concentration difference and distribution. The gradients generated by the 
horizontal inlets were larger than those created by the diagonal inlets. Thus, by a 
simple adaptation in the orientation of the inlets the concentration gradients within the 
explant could be varied in a controlled manner. 
 
Experimental measurement of glucose gradient in explants. 
In the square cartilage explants without compression, some cell death was observed 
at the lateral sites of the explant likely due to sample processing (insert ref). Hardly 
any cell death was observed in the top, in the center or bottom of the cartilage 
explant either in static or dynamic culture. Cartilage explants were successfully 
cultured for up to 7 days without loss of viability (data not shown). This showed that 
limitation of diffusion by confinement of the explant was not a limiting factor for 
chondrocyte survival.To validate the predicted gradient (Figure 3A), cartilage 
explants were subsequently dynamically cultured for 3 days using medium containing 
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25 mmol/L of glucose in the top compartment and medium containing 0 mmol/L of 
glucose in the bottom compartment. Figure 3B shows the glucose concentration in 
the top, middle and bottom layer of the explants after 3 days of culture. The 
concentration decreased with depth and the concentration in the top layer 
significantly differed from the one in the bottom layer. The decrease in concentration 
from top to bottom suggests that a gradient can be formed during 3 days of culture. 
However, the experimental values did not fully comply with the computational model. 
This is most likely due to the fact that the diffusion coefficient of glucose through the 
tissue, in contrast to the model, is not homogenous, but differs from zone to zone. 
Another possibility could be that permeability of the tissue is higher than what is 
assumed in our model [33, 34].Regardless, we validated the formation of a 
biologically relevant gradient using the dual flow-approach. 
 
Gradient formation of cartilage degrading enzymes 
We next assessed whether gradients in the explants could also be obtained by larger 
molecules like proteins. For this we used enzymes involved in cartilage degradation 
as model compounds. Several enzymes involved in cartilage degradation enter the 
cartilage via the synovial fluid [35, 36]. In our models we mimicked this by culturing 
explants using two physically separated medium compartments that are located on 
either side. The medium on the synovial side of the explant was supplemented with 
either hyaluronidase or collagenase. After 7 days of culture, explants were stained for 
sGAGs and collagens. Safranin-O and Picrosirius Red staining revealed a loss of 
sulphated GAGs or collagen, respectively, at the synovial side of the cartilage as 
compared to a freshly isolated sample (Figure 4A and C). Moreover, there was no 
loss at the lateral sides or the subchondral side indicating the absence of leakage. 
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Quantification of the histological section showed a significant decrease in matrix 
components (Figure 4B and D). In addition, no matrix degradation on the lateral sides 
of the explants could be observed. This strongly suggests that the system does not 
suffer from leakage ensuring that the additives from the top compartment can only 
reach the bottom compartment via diffusion through the tissue. Taken together, our 
bioreactor set up this system allows for the creation of gradients of molecules of 
choice through cartilage explants.  
 
Compression and cell viability. 
We next examined the effect of compression on chondrocyte viability. Square 
cartilage explants were compressed for 24 hours (1 hour compression, 7 hours rest 
with 0,25MPa compressive load (~2.5% strain) at 0,33Hz) and a live dead assay was 
performed. In remarkable contrast to static or dynamic culture of cartilage explants 
which showed negligible cell death in top and bottom cell layers of the explant (data 
not shown), considerable cell death was observed after 24 hours at the top and 
bottom of the explant (Figure 5). Most cell death was noted at the top edges of the 
explant (Figure 5, arrow), while cell death in the top central part of the explant was 
reduced (Figure 5, asterisk).  Chondrocytes in the middle of the explant did not show 
evidence of increased cell death. Cell death at the lateral sites was more pronounced 
than in static or dynamic culture.  
We reasoned that the square compression plate which tight fitted in the cartilage 
inserts used for explant culture was responsible for the increased cell death in 
particular at the top lateral sites of the explant. This design was not compatible with 
tissue expansion and deformation upon compression likely resulting in high stresses 
at the borders of the explant resulting in the observed cell death. To test this we 
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redesigned the inset for explant culture in the bioreactor and the compression 
module. The new inset is designed for culturing cylindrical osteochondral plugs with a 
width of 7mm. The top of the compression module was rounded and made out of 
teflon instead of metal. The rounded tip is compatible with tissue deformation at the 
lateral sides. Like the square cartilage explants, the cylindrical osteochondral plugs 
could be isolated and cultured in the bioreactor either statically or dynamically without 
noticeable cell death of chondrocytes anywhere in the explant for up to 2 weeks (data 
not shown). Interestingly and in marked contrast to the previous design. 24 hours of 
compression (1 hour compression, 7 hours rest with 0,25MPa compressive load 
(~2.5% strain) at 0,33Hz) dramatically reduced the thickness of layers with cell death 
at the top, bottom, and lateral sites of the cartilage explants from  on average 8% to 
less than 0.2% of total construct height or width (Figure 5). Also the cell death at the 
top lateral sites was markedly reduced. 
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Discussion 
This study reports on the development of a novel bioreactor for cartilage tissue 
engineering. Our design is unique due to the incorporation of both confined cyclic 
mechanical loading and nutrient supply via diffusion from both the top and bottom 
separately. This form of nutrient supply resembles the natural situation in native 
cartilage. The combination of both features in one bioreactor set up generates a 
system that more closely resembles the native environment of articular cartilage 
compared to previously reported bioreactors [22-24]. We successfully succeeded in 
culturing cartilage explants and osteochondral plugs in our bioreactor for up to 2 
weeks in static or dynamic flow without any significant cell death in the cartilage 
layers. In the square cartilage explants some cell death was noted in peripheral 
layers at the lateral sites of the construct. These likely arise as a consequence of 
cutting the cartilage [37, 38]. The data do indicate, however, that in our design 
diffusion of nutrients, oxygen and waste products from top or bottom is sufficient to 
keep middle zone chondrocytes alive. 
Computational modeling predicted that our design is suitable for the formation of 
gradients of small molecules like glucose and oxygen in cartilage explants. The 
formation of these these gradients can be manipulated with simple modifications in 
the design by changing the position of the inlets for dynamic flow or by varying the 
nutrient concentrations above or below the construct. The design allows to explore 
the effect  of gradients of a wide variety of molecules on healthy and tissue 
engineered cartilage [31, 39] and to test the hypothesis that gradients of signaling 
molecules are important for reconstructing cartilage’s zonal architecture. For 
nutrients, like glucose, there is little known how the gradient in articular cartilage 
looks like. Since middle and deep zone chondrocytes rely on diffusion from either the 
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synovial fluid or subchondral bone compartment it is likely that such gradient exist. In 
line with this, Heywood et al described differences in metabolic responses in 
chondrocyte subpopulations,which may be involved in establishing specific zonal 
phenotypes [31, 40]. We performed two experiments to demonstrate the formation of 
a gradient in tissue explants cultured in our bioreactor by varying the concentration of 
compounds in the top and bottom compartment. First we used glucose as a model 
compound for nutrients and added a concentration of 25mM in the top compartment 
and 0mM in the bottom compartment. Experimentally a glucose gradient was 
detected across the cartilage explant. This experimental gradient did it did not exactly 
match the predicted one by computational modeling. In computational models it is 
assumed that the glucose consumption rate in cartilage is homogenous, however in 
reality it is not [30]. This is an important notion as it may also hold true for other 
nutrients as well as growth factors. For secreted soluble growth factors the 
abundance, their zonal distribution and the  affinity and abundance of receptors for 
these factors will also play an important role. All these parameters, of which many are 
still unknown will affect the diffusion of growth factors and nutrients and thus the 
nature of a gradient. Fundamental knowledge regarding diffusion coefficients of many 
nutrients and growth factors in cartilage is also lacking. All these factors likely 
contribute to the the deviation in our modeled glucose gradient versus the 
experimentally determined values. It should be noted that the computational 
modeling and the experimental gradient across a cartilage explant were studied in 
the absence of mechanical load. Mechanical compression likely affects the diffusion 
of molecules in the cartilage as it results in water displacement. However, the true 
nature of the effects remains largely unknown. Our bioreactor can function as an 
enabling technology that can facilitate in depth studies of these topics.  
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Besides glucose, two proteins were used to study the formation of a gradient, namely 
hyaluronidase and collagenase. These enzymes were added in the top compartment 
mimicking their presence in synovial fluid as in osteoarthritis [35, 36]. By studying the 
depletion of sGAGs and collagen from the tissue using histological staining the 
formation of gradients could be easily studied. The results show that the absence of 
leakage at the lateral sites of the explant and the formation of a top down gradient. 
They demonstrate the feasibility of our design to build gradients of proteins in 
explants. 
Next to culturing explants in an environment that mimics the natural situation in 
several key features, we hypothesize that creating gradients in a controlled way can 
contribute to the development of tissue engineered grafts closely resembling 
cartilage’s natural architecture in vitro. Current research focuses on elucidating what 
concentration ranges stimulate the expression of zone specific proteins like 
superficial zone protein, cartilage intermediate layer protein and cartilage oligomeric 
matrix protein [41]. Introduction of gradients may contribute to native matrix 
distribution in tissue engineered cartilage. In addition, the effect of compression on 
these developing constructs can be studied in depth using this bioreactor. 
Although rotating compression can best simulate the natural load of the joint, it is less 
controllable than confined or sliding compression, as different forces are exerted on 
the tissue (indentation and rotation) and each can have different effects on the tissue. 
Since load is an important feature in cartilage development, we complemented the 
two compartment bioreactor with confined compression. When confined compression 
was applied to square cartilage explants using a tight fit perforated metal plate 
substantial cell death was noted at the periphery of the explant particularly at the top 
lateral sites. This is likely explained by the design of the bioreactor’s insets which did 
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not allow tissue deformation as response upon load resulting in high stresses at the 
periphery of the construct and consequently cell death. This issue could be easily 
solved by adapting the inset for explant culture as well as the module used for 
confined compression. The new inset is compatible with the culture of cylindrical 
cartilage explants. Cylindrical osteochondral plugs can be easily isolated using 
standardized orthopedic equipment. For confined compression a rounded module 
was used made out of teflon. The mechanical properties of teflon better resemble the 
mechanical properties of native cartilage compared to metal. In addition, the rounded 
surface of the tip is compatible with tissue expansion at the lateral sites upon load. 
Using this new design negligible cell death was observed at the periphery of the 
cartilage explant. Besides the possibility for tissue expansion at the lateral sites upon 
load, the use of Teflon instead of metal for compression and the cylindrical shape of 
the explant may also contribute to improved cell survival upon load. Using this new 
design it will be possible to culture chondral or even osteochondral explants or tissue 
engineered constructs for prolonged periods of time in the bioreactor and study the 
role of compression. 
Our system is advantageous over current mechano-perfusion bioreactor systems for 
cartilage tissue engineering as it is not based on convection but on diffusion from 
physiologically relevant sides. This more closely mimics the natural environment of 
articular cartilage. This strategy allows us to take advantage of a two compartment 
system generating biologically relevant gradients in a tissue engineered construct or 
explant culture. These gradients can be modulated by applying different 
concentrations of molecules of interest in each compartment. In addition, the gradient 
can be controlled by changing the orientation of the medium inlets.  
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Using simple modifications in our system we can include other tissues such as bone 
and synovial tissue. This would further increase the resemblance of the micro-
environment generated in our system to the native environment of cartilage. 
Moreover, with the addition of bone by explant culture of osteochondral plugs and/or 
synovium it is able to function as a more accurate ex-vivo model for degenerative 
cartilage diseases such as osteoarthritis when compared to standard explants 
cultures. Particularly, it incorporates the idea that osteoarthritis is not a single tissue 
disease but a joint disease [42-45].  
 
In summary, we have developed a unique bioreactor system that captures two key 
features of cartilage’s natural environment. It has the ability to create gradients of 
nutrients and growth factors and apply confined cyclic compression. We believe that 
this will aid in development of an in vitro environment for cartilage homeostasis 
facilitating neo-cartilage formation. Therefore, our bioreactor holds the potential to 
grant deeper insight in fundamental concepts of cartilage biology, model 
degenerative cartilage diseases like osteoarthritis and stimulate the development of 
novel therapeutics for such diseases.  
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Figure 1: A novel bioreactor for articular cartilage explants. (A) A lateral view of the 
mechano-dual flow bioreactor. (B) A top view of dual compartment bioreactor for 
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static culture. (C) A knife (top) for explant punch harvesting, an insert to 
accommodate squared cartilage explants (second from top) for bioreactor culture, an 
insert to house a cylindrical osteochondral explant (second from bottom) and a 
perforated plate to support explants (bottom). (D) A 4-module compression insert for 
the square explant samples (left) and a rounded compression module for the 
cylindrical explants (right).  (E) A plunger to harvest osteochondral explants (top) and 
a cartilage slicer to slice off full thickness cartilage slices (bottom). (G) Reproducible 
standardized articular cartilage cubes are obtained using the cartilage slicer in 
combination with the square knife (left). The inset shows explants in the knife, The 
height  of the cubes depended on the region of harvest. Cubes of one region were 
equal in height (right). 
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Figure 2: Computational modeling of the glucose and oxygen gradient formation 
within the explants in the dual flow bioreactor with two different designs. Prediction of 
the glucose gradient when horizontal (A) or diagonal (B) inlets are used.  Prediction 
of the oxygen gradient when horizontal (C) or diagonal (D) inlets are used. Dark red 
represents a [glu] of 25mmol/L and dark blue represents a [glu] of 0mmol/L and 
concentration decreases from dark red via orange and yellow to dark blue. The same 
holds for the [O2]. 
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Figure 3: Predicted and experimental glucose concentrations in different zones of 
articular cartilage. (A) Quantification of the modeled gradients, (B) Quantification of 
the glucose concentration in different zones after 3 days of dynamic culture 
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(*=P<0,05, n=10). The data is represented as the mean glucose concentration/gram 
cartilage +/- the standard deviation of the mean. 
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Figure 4: Matrix degradation in a static dual compartment system. (A) Safranin-O 
stained explants cultured without and with hyaluronidase on top. A representative 
example out of 9 slides is shown. (B) Picrosirius Red stained explants cultured 
without and with collagenase on top (polarized light pictures). A representative 
example out of 7 slides is shown. (C) Quantification of GAG depletion in histological 
samples (n=9 slides from 4 explants). (D) Quantification of collagen depletion in 
histological samples (n=7 slides from 4 explants). The upward standard error bars 
belong to the bars representing the nonstained parts (red) and the downward errors 
bars to the stained parts (blue). Black and red arrow indicate the depth of matrix 
degradation.  
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Figure 5: Design validation. Live/dead assays were performed  on cartilage explants 
and on the cartilage in osteochondral explants after compression (24 hours (1 hour 
compression, 7 hours rest) with 0,25MPa compressive load (~2.5% strain) at 
0,33Hz). In both constructs, cell death was only noted in layers at the periphery of the 
cartilage explants but not in the center. A) Live/dead staining of a compressed 
cartilage explant. The arrow indicates the area where most cell death is observed. 
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The asterisk indicates the top center of the explant. B) Live/dead staining of a 
compressed osteochondral explant. The red staining in the lower part of the explant 
is due to non-specific binding of the ethidium homodimer to mineralized bone matrix. 
A representative example out of 3 specimens is shown. C) Quantification of A and B. 
The thickness of the layers was measured and expressed as % +/- standard 
deviation of the total height at the top or bottom or width of the cartilage explant at 
the lateral sites.  (n=5 (articular cartilage model), n=3 (osteochondral model)). 
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